Liminatus Pharma sets 1-for-50 reverse stock split effective Aug. 20

Reuters2026/08/18 20:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Liminatus Pharma will execute a 1-for-50 reverse stock split of its common stock effective at the Aug. 20 close.
Shares are expected to trade on a split-adjusted basis on Nasdaq under LIMN at the Aug. 21 open.
Outstanding shares would fall from 67,160,362 to about 1,343,208 on a pro forma July 2 basis.
Fractional shares will be rounded up to the nearest whole share.
New post-split CUSIP: 53271X 207.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608181601PRIMZONEFULLFEED9812156) on August 18, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Liminatus Pharma sets 1-for-50 reverse stock split effective Aug. 20

You may also like

Crypto prices